Comprehensive review highlights probiotics' role in modulating the gut microbiome and improving MASH outcomes.
Key Points
Probiotics may improve symptoms of metabolic dysfunction-associated steatohepatitis by modulating the gut microbiome.
Emerging research shows probiotics significantly impact gut-liver axis interactions in metabolic dysfunction-associated steatohepatitis.
The review synthesizes evidence from clinical trials on the efficacy of different probiotic strains for metabolic dysfunction-associated steatohepatitis.
Probiotic-based interventions for metabolic dysfunction-associated steatohepatitis present opportunities, challenges, and avenues for future research.